| Authors: |
Reutens AT; Clinical Diabetes and Epidemiology, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia., Lekamlage DH; Diabetes and Population Health, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia; The Institute for Mental and Physical Health and Clinical Translation (IMPACT), Deakin University, Geelong, Victoria, Australia., Salim A; Diabetes and Population Health, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia; School of Mathematics and Statistics, The University of Melbourne, Melbourne, Victoria, Australia., Shaw JE; Clinical Diabetes and Epidemiology, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia; Diabetes and Population Health, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia; School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia., Esler MD; Human Neurotransmitter Laboratory, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia; Department of Cardiology, Alfred Hospital, Melbourne, Victoria, Australia., Cooper ME; Department of Diabetes, Monash University, Central Clinical School, Melbourne, Victoria, Australia., Kaye DM; Department of Cardiology, Alfred Hospital, Melbourne, Victoria, Australia; Heart Failure Research Group, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia; Monash Alfred Baker Centre for Cardiovascular Research, Monash University, Melbourne, Victoria, Australia. Electronic address: david.kaye@baker.edu.au. |
